+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endometriosis Treatment Market by Treatment Type (Complementary Therapies, Hormonal Therapies, Pain Management), Route Of Administration (Injectable, Oral, Topical), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Endometriosis Treatment Market by Treatment Type (Complementary Therapies, Hormonal Therapies, Pain Management), Route Of Administration (Injectable, Oral, Topical), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Endometriosis Treatment Market by Treatment Type (Complementary Therapies, Hormonal Therapies, Pain Management), Route Of Administration (Injectable, Oral, Topical), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989704
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endometriosis Treatment Market is rapidly evolving as the focus on precision medicine and patient-centric care intensifies. Stakeholders across healthcare, pharma, and medtech are poised to capitalize on innovative therapies, digital health solutions, and advanced diagnostic modalities that address substantial unmet patient needs.

Market Snapshot: Endometriosis Treatment Market Growth Trajectory

The Endometriosis Treatment Market grew from USD 3.05 billion in 2024 to USD 3.28 billion in 2025. It is expected to continue growing at a CAGR of 7.39%, reaching USD 4.68 billion by 2030. Market expansion is being shaped by breakthrough innovations, heightened awareness, and an increasing drive for patient-centric healthcare models. Enhanced diagnostic capabilities and a broader therapeutic toolkit are improving care outcomes and supporting evolving industry strategies.

Scope & Segmentation

This report comprehensively analyzes the endometriosis treatment landscape, segmenting the market along multiple relevant axes:

  • Treatment Types: Complementary therapies, hormonal treatments (aromatase inhibitors, GnRH agonists/antagonists, oral contraceptives, progestins), pain management (NSAIDs: diclofenac, ibuprofen, naproxen; opioids: codeine, morphine), surgical interventions.
  • Route of Administration: Injectable, oral, topical treatment modalities.
  • End User Channels: Ambulatory surgical centers, hospitals, specialty clinics.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • Regions Covered: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Technologies & Companies: Includes advances in immunomodulation, biomaterial delivery, digital health, and solutions offered by leaders such as AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Pfizer Inc., and others.

Key Takeaways and Strategic Insights

  • Adoption of precision medicine is enabling tailored treatments, reducing trial-and-error prescribing, and widening access to effective interventions.
  • Digital health platforms and remote monitoring improve patient engagement and support continuity of care, especially in underserved regions.
  • The rise in minimally invasive surgical techniques and advanced pain management broadens therapeutic choice and enhances patient satisfaction.
  • Regional diversity in regulatory policy, infrastructure, and reimbursement frameworks requires tailored strategies for successful market entry and sustained growth.
  • Collaboration between pharmaceutical, biotech, device manufacturers, and advocacy organizations is accelerating innovation, portfolio diversification, and real-world implementation.
  • Lifecycle management and investment in emerging technologies, such as AI analytics and companion diagnostics, are supporting long-term competitive positioning.

Tariff Impact: United States Dynamics

Recent United States tariff adjustments are contributing to supply chain complexity and cost escalation for key commodities, ranging from pharmaceutical ingredients to medical devices and packaging. Industry responses include exploring alternate sourcing, repatriating manufacturing, and renegotiating supplier agreements. While some organizations absorb added costs to maintain competitive pricing, others diversify production to mitigate future risk. These measures impact therapy accessibility and have prompted payers to reassess reimbursement strategies, positioning locally-optimized entrants for competitive advantage.

Methodology & Data Sources

This report leverages a balanced methodology, combining secondary research (literature, regulatory documents, industry papers) with primary interviews and surveys of clinicians, market leaders, and supply chain executives in endometriosis care. Rigorous data triangulation and benchmarking processes deliver actionable, high-confidence insights rooted in both qualitative and quantitative evidence.

Why This Report Matters

  • Delivers actionable intelligence for senior leaders who must align R&D, supply chain, and commercial strategies with evolving therapeutic landscapes.
  • Provides granular segmentation and technology trends to support investment, partnership, and market entry decision-making in dynamic regional contexts.
  • Facilitates risk mitigation and opportunity identification by clarifying the effects of geopolitical shifts and payer policies on market performance.

Conclusion

The endometriosis treatment market is being redefined by advances in targeted medicine, digital care delivery, and strategic global partnerships. Decision-makers using this report gain a data-driven foundation to shape effective, future-ready strategies and maximize clinical and commercial outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of oral GnRH antagonists driving personalized treatment protocols with reduced side effects
5.2. Integration of digital health platforms for remote monitoring and symptom tracking in endometriosis management
5.3. Increasing clinical trials exploring selective estrogen receptor modulators for targeted endometrial lesion reduction
5.4. Expansion of minimally invasive robotic-assisted surgeries to improve patient recovery and fertility outcomes
5.5. Growth of biologics and immunomodulatory therapies aimed at inflammation control in chronic endometriosis cases
5.6. Rising investment in biomarker research for early noninvasive diagnosis and disease progression monitoring
5.7. Collaborations between pharmaceutical and diagnostic companies to develop companion diagnostic tests for hormone therapies
5.8. Development of implantable extended-release drug delivery systems for sustained endometriosis symptom relief
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Endometriosis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Complementary Therapies
8.3. Hormonal Therapies
8.3.1. Aromatase Inhibitors
8.3.2. Gnrh Agonists
8.3.3. Gnrh Antagonists
8.3.4. Oral Contraceptives
8.3.5. Progestins
8.4. Pain Management
8.4.1. Nsaids
8.4.1.1. Diclofenac
8.4.1.2. Ibuprofen
8.4.1.3. Naproxen
8.4.2. Opioids
8.4.2.1. Codeine
8.4.2.2. Morphine
8.5. Surgical Treatment
9. Endometriosis Treatment Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Endometriosis Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Endometriosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Endometriosis Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Endometriosis Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Endometriosis Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Bayer AG
15.3.3. Teva Pharmaceutical Industries Ltd
15.3.4. Ferring International Center S.A.
15.3.5. Mylan N.V.
15.3.6. Sandoz International GmbH
15.3.7. Lupin Limited
15.3.8. Pfizer Inc.
15.3.9. Sun Pharmaceutical Industries Ltd
15.3.10. Dr. Reddy’s Laboratories Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENDOMETRIOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ENDOMETRIOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ENDOMETRIOSIS TREATMENT MARKET: RESEARCHAI
FIGURE 24. ENDOMETRIOSIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. ENDOMETRIOSIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. ENDOMETRIOSIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENDOMETRIOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 114. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 115. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 116. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 117. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 118. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 119. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 120. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 121. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 260. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 261. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 262. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 263. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 264. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 265. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 266. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 267. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025

Samples

Loading
LOADING...

Companies Mentioned

  • AbbVie Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • Ferring International Center S.A.
  • Mylan N.V.
  • Sandoz International GmbH
  • Lupin Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd
  • Dr. Reddy’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.68 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Endometriosis Drugs Market by Drug Class (Aromatase Inhibitors, GnRH Analogs, NSAIDs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Product Type, Route of Administration, End User, Mechanism of Action - Global Forecast 2025-2030 - Product Image

Endometriosis Drugs Market by Drug Class (Aromatase Inhibitors, GnRH Analogs, NSAIDs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Product Type, Route of Administration, End User, Mechanism of Action - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Endometriosis Market Report and Forecast 2025-2034 - Product Image

Endometriosis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Endometriosis Market Report by Type, Diagnosis and Treatment, End Users, and Region 2025-2033 - Product Image

Endometriosis Market Report by Type, Diagnosis and Treatment, End Users, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Endometriosis Market Report 2025 - Product Image

Endometriosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.